Thalidomide Stimulates T Cell Responses and Interleukin 12 Production in HIV-Infected Patients-Reference-Cited by-同舟云学术

Thalidomide Stimulates T Cell Responses and Interleukin 12 Production in HIV-Infected Patients

Published:1999-09 Issue:13 Volume:15 Page:1169-1179
ISSN:0889-2229
Container-title:AIDS Research and Human Retroviruses
language:en
Short-container-title:AIDS Research and Human Retroviruses

Author:

Haslett Patrick A.J.,Klausner Jeffrey D.,Makonkawkeyoon Sanit,Moreira Andre,Metatratip Prasit,Boyle Brian,Kunachiwa Warunee,Maneekarn Niwat,Vongchan Preeyanat,Corral Laura G.,Elbeik Tarek,Shen Zhu,Kaplan Gilla

Publisher

Mary Ann Liebert Inc

Subject

Infectious Diseases,Virology,Immunology

Link

http://www.liebertpub.com/doi/pdf/10.1089/088922299310269

Reference39 articles.

1. Clinical Evaluation of Branched DNA Signal Amplification for Quantifying HIV Type 1 in Human Plasma

2. Increases in CD4 T Lymphocytes with Intermittent Courses of Interleukin-2 in Patients with Human Immunodeficiency Virus Infection — A Preliminary Study

3. Effect of Immunization with a Common Recall Antigen on Viral Expression in Patients Infected with Human Immunodeficiency Virus Type 1

4. Increased Plasma Human Immunodeficiency Virus Type 1 Burden following Antigenic Challenge with Pneumococcal Vaccine

5. The Effect of Acute Infectious Illnesses on Plasma Human Immunodeficiency Virus (HIV) Type 1 Load and the Expression of Serologic Markers of Immune Activation among HIV‐Infected Adults

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Promising Potential of Curcumin and Related Compounds for Antiviral Drug Discovery;Medicinal Chemistry;2024-07

2. Immunotherapies inducing immunogenic cell death in cancer: insight of the innate immune system;Frontiers in Immunology;2023-11-23

3. Epigenetic Perspective of Immunotherapy for Cancers;Cells;2023-01-19

4. AMC-070: Lenalidomide Is Safe and Effective in HIV-Associated Kaposi Sarcoma;Clinical Cancer Research;2022-03-01

5. Key regulators of sensitivity to immunomodulatory drugs in cancer treatment;Biomarker Research;2021-06-05